Lifecore biomedical raises capital for growth with existing stockholder

Lifecore biomedical, inc. (“lifecore” or the “company”), a fully integrated contract development and manufacturing organization (“cdmo”), today announced the closing of a $5 million private placement (“pipe”) of its common stock with affiliates of wynnefield capital, inc. (“wynnefield capital”), a longtime stockholder of the company, at $7.97 per share.

LFCR Ratings Summary

LFCR Quant Ranking